Rekvina Laboratories Ltd.

Name: Rekvina Laboratories Ltd. Share Price Today, Stock Analysis
Brand: Rekvina Laboratories Ltd.

Stock Card

BSE: 526075

₹53.84

₹-1.09 (-1.98%)

As on 21-Sep-2026IST

Market cap

₹60 Cr

Revenue (TTM)

₹2 Cr

P/E Ratio

P/B Ratio

13.7

Div. Yield

0 %

Rekvina Lab Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 53.84 High: 53.84

52 Week Range

Low: 6.75 High: 59.40

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹0 Cr
ROE

0 %
ROCE

0 %
Industry P/E

47.47
EV/EBITDA

-180.3
Debt to Equity

-0.7
Book Value

₹3.9
EPS

₹-0.6
Face value

5
Shares outstanding

11,115,750

10 Years Aggregate

CFO

₹-0.23 Cr

EBITDA

₹-0.77 Cr

Net Profit

₹-0.70 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Rekvina Lab	--	28.2	43.8	--	--	68.3	26.9
BSE Healthcare	19.8	2.6	8.7	14.9	22.4	14.8	12.2

As on 21-Sep-2026

Company	2016	2015	2014
Rekvina Lab	-2.9	-51.8	79.9
BSE Small Cap	1.8	6.8	69.2
BSE Healthcare	-12.9	15.1	47.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Rekvina Lab	53.8	59.9	1.9	-0.3	-17.6	--	--	13.7
Acutaas Chemicals	3,425.7	28,018.8	1,461.8	387.4	34.5	25.2	72.5	16.2
Alembic Pharma	848.8	16,714.8	7,784.0	688.5	10.6	14	24.1	2.9
Cohance Lifesciences	460.5	17,622.4	2,141.5	58.5	5.8	3.3	165.9	4.6
Granules India	875.2	23,880.5	5,632.3	662.4	17.2	14.3	36.1	4.9
Jubilant Pharmova	1,049.3	16,715.8	8,608.3	351.6	8.7	5.7	47.5	2.3
Onesource Specialty Pharma	1,599.2	18,349.4	1,543.3	-48.6	3.6	-0.6	--	3.1
Piramal Pharma	214.7	28,577.4	9,205.3	-371.8	1.7	-3.8	--	3.6
Rubicon Research	1,732.6	28,658.5	1,935.8	288.2	20.6	29.8	99.4	21.3
Wockhardt	2,187.3	35,547.6	3,564.0	414.0	15.3	8.4	86.9	7.1

Shareholding Pattern

View Details

News & Analysis

All News

No Review & Analysis are available.

About Rekvina Lab

Rekvina Laboratories Limited manufactures and markets pharmaceutical products in India. The company was incorporated in 1988 and is based in Vadodara, India.

Incorporated

1988
Chairman

Ilaben Pathak
Managing Director

Amit Shah
Headquarters

Vadodara, Gujarat
Website

www.rekvinalaboratories.com

FAQs for Rekvina Lab

What is the current share price of Rekvina Laboratories Ltd Today?

The share price of Rekvina Laboratories Ltd is ₹53.84 (BSE) as of 21-Sep-2026 IST. Rekvina Laboratories Ltd has given a return of --% in the last 1 years.

What is the current PB & PE ratio of Rekvina Laboratories Ltd?

Since, TTM earnings of Rekvina Laboratories Ltd is negative, P/E ratio is not available.
The P/B ratio of Rekvina Laboratories Ltd is 13.66 times as on 21-Sep-2026, a 183 premium to its peers’ median range of 4.83 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	0.00	0.00
2024	0.00	0.00
2023	0.00	0.00
2022	0.00	0.00
2021	0.00	25.79

What is the 52 Week High and Low of Rekvina Laboratories Ltd?

The 52-week high and low of Rekvina Laboratories Ltd are Rs 59.40 and Rs 6.75 as of 22-Sep-2026.

What is the market cap of Rekvina Laboratories Ltd?

Rekvina Laboratories Ltd has a market capitalisation of ₹ 60 Cr as on 21-Sep-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Rekvina Laboratories Ltd?

Before investing in Rekvina Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.